ImmunologyNature ImmunologyPeer-reviewed
mRNA-based tuberculosis vaccines BNT164a1 and BNT164b1 are immunogenic, well-tolerated and efficacious in rodent models
Neha Agrawal, Louis S. Ates, Stefan A. Schille…·Uğur Şahin
This paper describes two mRNA vaccines for tuberculosis that are immunogenic, well-tolerated, and effective in rodent models, entering clinical trials.